This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa | 
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa | 
|---|---|---|---|---|---|---|
The Quest AD-Detect® blood-based test panels deliver confirmatory accuracy, potentially supporting reduced reliance on PET-imaging confirmation SECAUCUS, N.J., Oct. 27, 2025 /PRNewswire/ -- Two...
Third quarter revenues of $2.82 billion, up 13.1% from 2024 Third quarter reported diluted earnings per share ("EPS") of $2.16, up 8.5% from 2024; and adjusted diluted EPS of $2.60, up 13.0% from 2024
Blood test to aid cancer treatment and recurrence monitoring now available from a German lab for potentially faster results HAMBURG, Germany, Oct. 17, 2025 /PRNewswire/ -- MVZ HPH Institute for...
Together with New Oura Ring 4 Charging Case, Multi-Ring Support, and In-App Bloodwork with Health Panels, the Ceramic Collection Gives Members More Freedom, Style, and Deeper Health Insights SAN...
Over 350,000 members have joined the waitlist since May, underscoring the excitement for one product that can pair blood biomarkers with 24/7 wearable data BOSTON, MA — [September 30, 2025] —...